Viral exanthems and other dermatologic infections/inflammations - Stillwell Flashcards
exanthema
-widespread rash - caused by toxins, drugs, infection, autoimmune
enanthem
-rash on mucous membrane (ex. mouth, nose)
macule
- flat lesion on the surface of skin (not raised)
- <2cm; patch if >2cm diameter
- ex. freckle
papule
- small lesion raised above the skin
- <0.5 cm; nodule (0.5-5cm); tumor >5cm
plaque
- large, flat topped raised lesion
- > 1cm
- ex. psoriasis or eczematous dermatitis
pustule (pimple)
- small collection of pus in epidermis/dermis
- may form to papule –> collection of inflammatory cells
- small abscess
vesicle
- small fluid filled lesion above the skin (translucent)
- <0.5 cm
- may be grouped
- ex. HSV-1 - fever blister on lip
bulla
- fluid filled lesion above the skin (translucent)
- > 0.5 cm
- ex. 2nd degree burn or pressure blister
morbilliform rash
- diffuse rash sometimes showing circular or elliptical lesions
- ex. measles, drug/allergic rxns, syphilis
viral exanthems/enanthems
- viral syndrome includes fevers, chills, myalgias, arthralgias, fatigue (may or may not have a rash)**
- rash may be from virus itself or immune response
- low WBCs, platelets, sometimes anemia
- ESR, CRP, procalcitonin usually normal
alpha herpes viruses**
HHV-1 (Herpes simplex virus-1/HSV-1) (oral>genital herpes)
HHV-2 (Herpes simplex virus-2/HSV-2) (genital>oral herpes)
HHV-3 (Varicella zoster virus- VZV) (chickenpox/shingles)
HHV-B (Herpes simiae virus- Herpes B virus) (rash/meningoencephalitis/lymphadenitis)
gamma herpes viruses**
HHV-4 (Epstein-Barr virus- EBV) (infectious mononucleosis)
HHV-8 (Kaposi’s sarcoma herpesvirus- KSHV) (Kaposi’s sarcoma)
beta herpes viruses**
HHV-5 (Cytomegalovirus- CMV) (infectious mononucleosis)
HHV-6 (Roseolovirus) (roseola)
HHV-7 (Roseolovirus) (roseola)
herpes group viruses
- DNA viruses - DNA in capsid wrapped within a tegument with with the virion as the envelop
- latently infect cells (LAT genes) - can reactivate
- may live the rest of someone life
- may or may not be symptomatic
HSV-1
- most people carry it latently
- can reactivate and spread when there are no symptomatic lesions** (reactivate less frequently than HSV-2)
- usually oral** - ex. fever blisters on the lip
- 80-90% usually orolabial, 10-20% genital
- can occur on skin (herpes gladitorium - no dermatome)** and around fingertips (herpetic whitlow) and perianally**
- begins with preherpetic neuralgia** (pain and tingling) –> progress to ulcers
- primary infection worse than recurrences** –> febrile illness, lesions, ulcerative stomatitis**
- no longer contagious once the scab crusts
- prophylaxis can abort virus
HSV-2
- less people carry virus latently; more common in women
- can reactive and spread when there are no symptomatic lesions** (reactivates more frequently than HSV-1)**
- 80-90% genital, 10-20% orolabial**
- primary infection more severe than recurrences –> febrile, lesions, vaginitis, urethritis, urinary retention, inguinal lymphadenitis**
- begin with preherpetic neuralgia –> vesicles –> ulcers
HSV-1,2
- treatment: acy/penci/famci/valacyclovir**
- prophylaxis: condoms, oral meds –> lowers reactivation risk and makes it less severe
- diagnosis: usually clinical, antibodies ineffective bc would cross react
- Tzanck smear from ulcer –> multinucleated giant cells*
- best is PCR test of swab of lesion* - immunity: cell mediated immunity** - not much problem if antibodies are low, but problem with low T cells (immunosuppressed people)
varicella zoster - HHV-3
- epidemiology: acquire through inhalation
- will normally get it if not immune (vaccinated)
- primary infection (chickenpox aka varicella) –> lead to pneumonia and meningitis/encephalitis**; secondary bacterial infections in child
- remains dormant in CN5 and dorsal root ganglia and reactivates into shingles (herpes zoster) - risk increases with age - clinic: vesiculated lesions that come in crops*
- reactivation to shingles follows single dermatome
- reactivation can develop postherpetic neuralgia (chronic pain) with shingles**
- if reactivated in trigeminal nerve –> cornea is at risk** - treat: acy/famci/valacyclovir or VZV Igs
- prophylaxis:
- viravax (live) for children
- zostavax (live) given to adults –> decreases risk of reactivation and post herpetic neuralgia
- shingrix (recombinant) given to elderly –> go to treatment - diagnosis: clinic or PCR
chickenpox vs smallpox**
- chickenpox - lesions are crops over time, easily crusts, mild illness before rash, spares palms/soles**
- smallpox - lesions all at once, takes days to crust, sever illness before rash, affects palms/soles**
HHV-6, HHV-7 (roseola) aka exanthem subitum
- epidemiology: spread through saliva or mother to baby, frequent in children
- clinic: high fevers and febrile seizures, rash starts on trunk and moves peripherally
- similar to measles, but does not look as sick in roseola - treat: supportive
- prophylaxis: no vaccine
HHV-8 (kaposi’s sarcoma)
- epidemiology: seroprevalence increases with age/sex partners
- pass from mother to child, body fluids (sexual contact) - clinic: associated with kaposi’s sarcoma tumor in immunocompromised (ex. AIDS - low CD4)**
- associated with multicentric Castleman’s disease
- purplish-violet lesions on MOUTH and NOSE** - treat: boost immune system with HAART
- prophylaxis: safe sex; no vaccine
Herpes B virus (Herpes simiae)
- epidemiology: virus in macaque/rhesus monkeys**
- acquire from bite or secretions - clinic: lesions similar to HSV (gladiatorum)
- also pharyngitis, lymphadenitis, meningoencephalitis –> death - treat: acyclovir immediately
- prophylaxis: no vaccine
hand, foot, and mouth disease (coxsackie virus A16 - sometimes enterovirus-17)**
- epidemiology: highly contagious
- transmitted by nasopharyngeal, fecal-oral, air droplets, direct contact
- usually in children under 10
- polio like illness in adults - clinic: papules, vesicles, ulcers on hands, feet, mouth
- nonpruritic rash involving the palms/soles**
- grey-white lesions with ulcers in the back of mouth - treat: none
- prophylaxis: no vaccine in US, is vaccine in China
herpangina (coxsackie virus A and B, enterovirus 71, sometimes echovirus)**
- epidemiology: spread in summer in respiratory droplets or fecal-oral, children under 10
- clinic: within couple days, grayish lumps develop into vesicle in the in mouth and pharynx (often soft palate and tonsils) and get bigger
- looks like herpes stomatitis or hand-foot-mouth disease - treat: none
- prophylaxis: no vaccine